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Odell et al., should be commended on an important
study for chiropractic treatment of chronic migraine [1].
However, in my opinion, there are some significant limi-
tations in the design of the trial.
Firstly, with the trial having no placebo/sham group,
the strength of the trial is decreased, and any potential
conclusions will be significantly limited [2]. I suggest the
authors consider adding a possible placebo/sham arm of
the trial, which could include:
 Sham SMT [3]
 Detuned interferential/ultrasound [4]
 Placebo pharmaceutical, such as a “muscle relaxant”
 Detuned TENS or “Cefaly” (which is a brand name
for an external trigeminal nerve stimulator) [5]
Alternatively, the authors could consider comparing
mobilisation of the neck to SMT as separate cohorts,
and not in the current method as a pragmatic study,
where participants may receive either or both
(dependent on practitioner discretion).
Secondly, I believe the study contains significant atten-
tion bias difference due to participants receiving five
SMT sessions in comparison to no treatment sessions
for care as usual (CAU) cohort. This will also potentially
add to poor method scores in patient “blinding”, as it
should be obvious participants in the SMT cohort, that
they have received therapeutic treatment, versus no
treatment in the CAU cohort [2].
In addition, there are some concerns over the total
number of outcome measures (ten) and poor compliance
from participants due to the time to complete all out-
come measures thoroughly. I wish the authors good luck
in completion of this study.
Response from the authors
Jim Odell, Carol Clark, Adrian Hunnisett, Osman Hassan Ahmed and Jonathan Branney
The authors would like to thank Associate Professor
Tuchin for taking the time to write to the editor about
our protocol [1]. The issues raised are important and
ones that we considered before undertaking the study.
With regard to the question on placebo arm, we
accept that it may have been useful, although on the
other hand introducing a valid placebo in any manual
therapy randomised controlled trial (RCT) is difficult
and rarely removes or accounts for all components of
the placebo effect. However, we recognise some studies
have attempted to do so [6, 7] and it is a future area for
development.
In this study our objective was a pragmatic one, de-
signed to aid real-world clinical decision making on
treatment rather than understanding the causal nature
of the relationship [8]. The design was therefore ‘add-
on’. Some authors have suggested that the aim should be
to identify the benefit to the patient regardless of the
source; psychosocial or biological, particularly where risk
to the patients is low [9, 10].
With regard to the suggestion of comparing mobilisa-
tion and spinal manipulative therapy (SMT) this is cer-
tainly a study that can be carried out in the future. We
chose to explore the effectiveness of manual therapy
(MT) (without specifying one type), as it was felt that
this is what best mirrors clinical practice, and as such
makes this a pragmatic trial.
We are unaware of the use of the specific term ‘atten-
tion bias’ but understand the point made. All participants
were contacted every week for diary data, often with the
non MT group more forthcoming, which may mitigate
some of the suggested bias differential. However we are
unaware of measures that quantify the impact of ‘atten-
tion’ bias. The ‘blinding’ however is an issue with this type
of study and will be reflected in discussion of the meth-
odological limitations rather than a score, which is not ap-
plicable to the CONSORT process [11, 12].
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The potential issues with compliance and outcome
measures were considered and efforts made to mitigate
these by involving people with chronic migraine in the
design of the outcome measure booklets and in trialling
the allocation of time to complete. We are able to report
that our initial results indicate that the primary outcome
measurement instruments were completed thoroughly.
However, we noted that not all the migraine diaries were
completed. This has provided us with valuable insights
for further trials in this population.
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